Recombinant monoclonal antibody to Myosin is a human antibody that can be potentially used in the treatment of cancers such as gastric cancer and colon cancer.
Figure 1 shows reactivity of GAH antibody with cultured cells and transplantation-derived cells of MKN45.
Figure 2 shows GAH antibody binding numbers, as a result of the evaluation of cell surface reactivity of GAH using a cell line stably expressing nmMHCA.
Figure 3 shows anti-nmMHCA antibody binding numbers, as results of the evaluation of cell surface reactivity of anti-nmMHCA antibody using a cell line stably expressing nmMHCA.
Figure 4 shows a relationship between the tumor growth inhibitory effect and the antigen amount per cell.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-450MZ-S(P) | Anti-Human MYH14 Recombinant Antibody scFv Fragment (GAH) | IP | Human antibody |
TAB-450MZ-F(E) | Anti-Human MYH14 Recombinant Antibody Fab Fragment (GAH) | IP | Human antibody |
There are currently no Customer reviews or questions for TAB-450MZ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.